The purpose of this study is to determine whether intravenous or oral iron are effective in the treatment of postoperative anemia and iron deficiency in patients submitted in postbariatric abdominoplasty.

Multicenter open randomized clinical trial with allocation ratio 1: 1. 56 adult patients undergoing post- bariatric abdominoplasty will be evaluated. The study group will receive 200 mg of intravenous iron in the immediate postoperative period and a second application on day 1 postoperatively. The control group will receive 100 mg of oral iron twice daily for 8 weeks. Haematological variables , iron 's profile , quality of life ( SF -36 and FACT- An) and adverse events will be assessed preoperatively and on the first , fourth and eighth weeks postoperatively .

Eligibility

Ages Eligible for Study:

18 Years to 55 Years (Adult)

Genders Eligible for Study:

Female

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Women

18 a 55 years

Prior open or laparoscopic standard limb Roux and Y gastric bypass

BMI < 32 kg/m2

Stability of weight loss for at least 6 months

grade 3 abdominal deformity on the Pittsburgh scale

Exclusion Criteria:

Illiterate

Current smoking

Prior IV iron use in the last 3 months

Uncontrolled systemic diseases

Hemoglobin < 11 g/dL

Ferritin <11 ng/mL

Ferritin > 100 ng/mL

transferrin saturation <16%

transferrin saturation> 50%

B12 < 210 pg/mL

Folic Acid < 3.3 ng/mL

Albumin < 2 g/dL

C reactive protein> 5 mg/L

Prior Anaphylactic reaction to IV iron

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01857011